Clinical Trial Update: A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase II study of irinotecan in patients with stage IIIB/IV or recurrent/metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Liaoning Cancer Hospital & Institute | Conditions: Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN